Physician

Vishal Sanjay Parikh, MD

According to 2025 Medicare claims, Vishal Parikh, MD (NPI: 1154664001) practices ophthalmology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is MIDWEST RETINA, INC (NPI: 1699846535; TIN: 311116017) and primary practice location at 43123-8650.

Parikh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 778 traditional Medicare patients, billed 32,207 HCPCS/CPT codes, and received $2,024,981 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 660 prescription claims across 182 beneficiaries totaling $25,740 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 36 records totaling $1,381. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $10,568 to $2,024,981. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $31,830 and ending at $25,740. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.0M2017 Medicare payment: $10,568 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $20,817 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $304,854 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,141,073 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,350,240 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,443,087 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,522,765 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,024,981 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20177586$10,568
2018146180$20,817
20193961,555$304,854
20206935,661$1,141,073
20218067,038$1,350,240
20227918,762$1,443,087
202376613,236$1,522,765
202477832,207$2,024,981

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$32K2015 Drug cost: $31,830 (USD; Tot_Drug_Cst)2016 Drug cost: $18,547 (USD; Tot_Drug_Cst)2017 Drug cost: $26,486 (USD; Tot_Drug_Cst)2018 Drug cost: $3,669 (USD; Tot_Drug_Cst)2019 Drug cost: $5,669 (USD; Tot_Drug_Cst)2020 Drug cost: $16,819 (USD; Tot_Drug_Cst)2021 Drug cost: $14,017 (USD; Tot_Drug_Cst)2022 Drug cost: $20,709 (USD; Tot_Drug_Cst)2023 Drug cost: $18,653 (USD; Tot_Drug_Cst)2024 Drug cost: $25,740 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015147621$31,830
2016166411$18,547
2017149499$26,486
201895161$3,669
201974132$5,669
2020125350$16,819
2021136389$14,017
2022157538$20,709
2023153488$18,653
2024182660$25,740

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more225278$94
92014Established patient complete exam of visual system392485$90
67028Injection of drug into eye3641,735$89
J3590Unclassified biologics203794$45
92134Imaging of retina6892,258$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium13600$9,652
Prednisolone AcetatePrednisolone Acetate1364,154$4,061
DifluprednateDifluprednate22723$1,659
Atropine SulfateAtropine Sulfate583,627$1,627
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1222,762$1,167

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$1,381Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vishal Sanjay Parikh, MD?

Tedicare shows public-source Medicare data for Vishal Sanjay Parikh, MD (NPI 1154664001), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vishal Sanjay Parikh, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vishal Sanjay Parikh, MD?

Vishal Sanjay Parikh, MD is linked to MIDWEST RETINA, INC (billing NPI 1699846535) in the available physician profile data.

Does Vishal Sanjay Parikh, MD have Open Payments data?

Vishal Sanjay Parikh, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.